Expert Opinion on Oncology

About this Collection

 

The Expert Opinion Collections are online feeds that group together Cover image of Oncology collection

articles published from across the Expert Opinion series by therapy

area.Articles from 2011 onwards are included.

 

Expert Opinion on Oncology focuses on R&D in cancer therapeutics. Treatments at all stages of development, for all types of cancers, are explored in-depth via Reviews and ‘Drug Evaluation’ articles contributed by leading oncologists and international experts.

 

 












All Articles

Showing 1 to 20 of 1123 Articles Left arrow
Previous page
Next page
Right arrow
Order results by:
Newest

Oldest

Most Read

Alert me when new articles are published in this collection

 

Selected Add to Favourites |
View Summaries |
Download Citation


1.
An update on emerging drugs for Hodgkin Lymphoma

Bastian von Tresckow, Volker Diehl

Posted online on 21 Apr 2022.

Summary | Full Text | PDF (395 KB) | PDF Plus (397 KB)
|
Add to Favourites
| Related 


2.
Novel genetic targets in endometrial cancer

Daphne W Bell

Posted online on 21 Apr 2022.

Summary | Full Text | PDF (177 KB) | PDF Plus (178 KB) | Supplemental Material
|
Add to Favourites
| Related 


3.
Animal models of urinary bladder cancer and their application to novel drug discovery

Paula A Oliveira, Regina Arantes-Rodrigues, Carmen Vasconcelos-Nóbrega

Expert Opinion on Drug Discovery May 2022, Vol. 9, No. 5, Pages 485-503
Summary | Full Text | PDF (444 KB) | PDF Plus (591 KB)
|
Add to Favourites
| Related 


4.
Phosphatase of regenerating liver: a novel target for cancer therapy

Amanda M Campbell, Zhong-Yin Zhang

Expert Opinion on Therapeutic Targets May 2022, Vol. 18, No. 5, Pages 555-569
Summary | Full Text | PDF (722 KB) | PDF Plus (815 KB)
|
Add to Favourites
| Related 


5.
The high mobility group A1 molecular switch: turning on cancer – can we turn it off?

Tait H Huso, Linda MS Resar

Expert Opinion on Therapeutic Targets May 2022, Vol. 18, No. 5, Pages 541-553
Summary | Full Text | PDF (488 KB) | PDF Plus (604 KB)
|
Add to Favourites
| Related 


6.
Dabrafenib for the treatment of melanoma

Rodabe N Amaria, Kevin B Kim

Expert Opinion on Pharmacotherapy May 2022, Vol. 15, No. 7, Pages 1043-1050
Summary | Full Text | PDF (283 KB) | PDF Plus (316 KB)
|
Add to Favourites
| Related 


7.
Use of mTOR inhibitors in the treatment of malignancies

Nisha A Mohindra, Francis J Giles, Leonidas C Platanias

Expert Opinion on Pharmacotherapy May 2022, Vol. 15, No. 7, Pages 979-990
Summary | Full Text | PDF (279 KB) | PDF Plus (378 KB)
|
Add to Favourites
| Related 


8.
Cell cycle inhibitors for the treatment of NSCLC

Marina Shcherba, Yuanxin Liang, David Fernandes, Roman Perez-Soler, Haiying Cheng

Expert Opinion on Pharmacotherapy May 2022, Vol. 15, No. 7, Pages 991-1004
Summary | Full Text | PDF (256 KB) | PDF Plus (324 KB)
|
Add to Favourites
| Related 


9.
Sipuleucel-T and immunotherapy in the treatment of prostate cancer

Nancy A Dawson, Erin E Roesch

Expert Opinion on Biological Therapy May 2022, Vol. 14, No. 5, Pages 709-719
Summary | Full Text | PDF (304 KB) | PDF Plus (366 KB)
|
Add to Favourites
| Related 


10.
Bevacizumab for the treatment of high-grade glioma: an update after Phase III trials

Mustafa Khasraw, Malaka Ameratunga, Christian Grommes

Expert Opinion on Biological Therapy May 2022, Vol. 14, No. 5, Pages 729-740
Summary | Full Text | PDF (258 KB) | PDF Plus (325 KB)
|
Add to Favourites
| Related 


11.
Anti-CD37 antibodies for chronic lymphocytic leukemia

Tadeusz Robak, Pawel Robak

Expert Opinion on Biological Therapy May 2022, Vol. 14, No. 5, Pages 651-661
Summary | Full Text | PDF (254 KB) | PDF Plus (314 KB)
|
Add to Favourites
| Related 


12.
Non-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma

Sara Tomei, Ena Wang, Lucia Gemma Delogu, Francesco M Marincola, Davide Bedognetti

Expert Opinion on Biological Therapy May 2022, Vol. 14, No. 5, Pages 663-686
Summary | Full Text | PDF (641 KB) | PDF Plus (839 KB)
|
Add to Favourites
| Related 


13.
The potential of pralatrexate as a treatment of peripheral T-cell lymphoma

Alessandra Dondi, Alessia Bari, Samantha Pozzi, Paola Ferri, Stefano Sacchi

Expert Opinion on Investigational Drugs May 2022, Vol. 23, No. 5, Pages 711-718
Summary | Full Text | PDF (266 KB) | PDF Plus (322 KB)
|
Add to Favourites
| Related 


14.
Investigational inhibitors of PTP4A3 phosphatase as antineoplastic agents

Elizabeth R Sharlow, Peter Wipf, Kelley E McQueeney, Ahmet Bakan, John S Lazo

Expert Opinion on Investigational Drugs May 2022, Vol. 23, No. 5, Pages 661-673
Summary | Full Text | PDF (700 KB) | PDF Plus (770 KB)
|
Add to Favourites
| Related 


15.
Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy

Carmen Criscitiello, Lucia Gelao, Giulia Viale, Angela Esposito, Giuseppe Curigliano

Expert Opinion on Investigational Drugs May 2022, Vol. 23, No. 5, Pages 599-610
Summary | Full Text | PDF (372 KB) | PDF Plus (456 KB)
|
Add to Favourites
| Related 


16.
Novel therapies, including enzastaurin, in the treatment of ovarian cancer

Ignace Vergote

Expert Opinion on Investigational Drugs May 2022, Vol. 23, No. 5, Pages 579-598
Summary | Full Text | PDF (335 KB) | PDF Plus (405 KB)
|
Add to Favourites
| Related 


17.
Heat shock protein 90 inhibitors in the treatment of cancer: current status and future directions

Komal Jhaveri, Stefan O Ochiana, Mark PS Dunphy, John F Gerecitano, Adriana D Corben, Radu I Peter, Yelena Y Janjigian, Erica M Gomes-DaGama, John Koren III, Shanu Modi, Gabriela Chiosis

Expert Opinion on Investigational Drugs May 2022, Vol. 23, No. 5, Pages 611-628
Summary | Full Text | PDF (756 KB) | PDF Plus (831 KB)
|
Add to Favourites
| Related 


18.
The clinical development of p53-reactivating drugs in sarcomas – charting future therapeutic approaches and understanding the clinical molecular toxicology of Nutlins

Swethajit Biswas, Emma Killick, Aart G Jochemsen, John Lunec

Expert Opinion on Investigational Drugs May 2022, Vol. 23, No. 5, Pages 629-645
Summary | Full Text | PDF (1143 KB) | PDF Plus (1256 KB)
|
Add to Favourites
| Related 


19.
Mitochondrial dynamics: biology and therapy in lung cancer

Frances E Lennon, Ravi Salgia

Expert Opinion on Investigational Drugs May 2022, Vol. 23, No. 5, Pages 675-692
Summary | Full Text | PDF (760 KB) | PDF Plus (873 KB)
|
Add to Favourites
| Related 


20.
Pharmacogenetic considerations for acute lymphoblastic leukemia therapies

Stéphanie Dulucq, Caroline Laverdière, Daniel Sinnett, Maja Krajinovic

Expert Opinion on Drug Metabolism & Toxicology May 2022, Vol. 10, No. 5, Pages 699-719
Summary | Full Text | PDF (483 KB) | PDF Plus (591 KB)
|
Add to Favourites
| Related 

Showing 1 to 20 of 1123 Articles Left arrow
Previous page
Next page
Right arrow